Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 1
2020 4
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
Allen-Philbey K, De Trane S, MacDougall A, Adams A, Bianchi L, Campion T, Giovannoni G, Gnanapavan S, Holden DW, Marta M, Mathews J, Turner BP, Baker D, Schmierer K. Allen-Philbey K, et al. Ther Adv Neurol Disord. 2023 Nov 10;16:17562864231200627. doi: 10.1177/17562864231200627. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37954917 Free PMC article.
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Allen-Philbey K, Stennett A, Begum T, Johnson AC, MacDougall A, Green S, Dobson R, Giovannoni G, Gnanapavan S, Marta M, Smets I, Turner BP, Baker D, Mathews J, Schmierer K. Allen-Philbey K, et al. Mult Scler Relat Disord. 2022 Sep;65:104022. doi: 10.1016/j.msard.2022.104022. Epub 2022 Jul 3. Mult Scler Relat Disord. 2022. PMID: 35816953 Free PMC article.
Evaluation of remote assessments for multiple sclerosis in an in-home setting.
Kuri A, Jacobs BM, Leddy S, Schmierer K, Turner B, Allen-Philbey K, Stennett A, Giovannoni G, Thomson A, Dobson R. Kuri A, et al. Among authors: allen philbey k. Mult Scler Relat Disord. 2021 Sep;54:103125. doi: 10.1016/j.msard.2021.103125. Epub 2021 Jun 29. Mult Scler Relat Disord. 2021. PMID: 34246018
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.
Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X, Yildiz O, Adams A, Bianchi L, Blain C, Chapman C, Chung K, Constantinescu CS, Dalton C, Farrell RA, Fisniku L, Ford H, Gran B, Hobart J, Khaleeli Z, Mattoscio M, Pavitt S, Pearson O, Peruzzotti-Jametti L, Scalfari A, Sharrack B, Silber E, Tallantyre EC, Webb S, Turner BP, Marta M, Gnanapavan S, Juliusson G, Giovannoni G, Baker D, Schmierer K. Allen-Philbey K, et al. Ther Adv Neurol Disord. 2021 Nov 25;14:17562864211057661. doi: 10.1177/17562864211057661. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 35173808 Free PMC article.
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.
Allen-Philbey K, Stennett A, Begum T, Johnson AC, Dobson R, Giovannoni G, Gnanapavan S, Marta M, Smets I, Turner BP, Baker D, Mathews J, Schmierer K. Allen-Philbey K, et al. Mult Scler Relat Disord. 2021 Jul;52:103028. doi: 10.1016/j.msard.2021.103028. Epub 2021 May 18. Mult Scler Relat Disord. 2021. PMID: 34049216 Free PMC article.
The impact of social capital on patients with multiple sclerosis.
Reyes S, Suarez S, Allen-Philbey K, Thomson A, Giovannoni G. Reyes S, et al. Among authors: allen philbey k. Acta Neurol Scand. 2020 Jul;142(1):58-65. doi: 10.1111/ane.13244. Epub 2020 Apr 7. Acta Neurol Scand. 2020. PMID: 32189325
Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial.
Topcu G, Smith L, Mhizha-Murira JR, Goulden N, Hoare Z, Drummond A, Fitzsimmons D, Evangelou N, Schmierer K, Tallantyre EC, Leighton P, Allen-Philbey K, Stennett A, Bradley P, Bale C, Turton J, das Nair R; NEuRoMS Collective. Topcu G, et al. Among authors: allen philbey k. Pilot Feasibility Stud. 2022 Jun 11;8(1):123. doi: 10.1186/s40814-022-01073-5. Pilot Feasibility Stud. 2022. PMID: 35690797 Free PMC article.
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S. Smets I, et al. Among authors: allen philbey k. Mult Scler Relat Disord. 2022 Jan;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22. Mult Scler Relat Disord. 2022. PMID: 34871856
15 results